What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes?
Open Access
- 24 November 2023
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 476 (4) , 673-688
Abstract
Acidosis is a chemical signature of the tumour microenvironment that challenges intracellular pH homeostasis. The orchestrated activity of acid-base transporters of the solute-linked carrier (SLC) family is critical for removing the end-products of fermentative metabolism (lactate/H+) and maintaining a favourably alkaline cytoplasm. Given the critical role of pH homeostasis in enabling cellular activities, mutations in relevant SLC genes may impact the oncogenic process, emerging as negatively or positively selected, or as driver or passenger mutations. To address this, we performed a pan-cancer analysis of The Cancer Genome Atlas simple nucleotide variation data for acid/base-transporting SLCs (ABT-SLCs). Somatic mutation patterns of monocarboxylate transporters (MCTs) were consistent with their proposed essentiality in facilitating lactate/H+ efflux. Among all cancers, tumours of uterine corpus endometrial cancer carried more ABT-SLC somatic mutations than expected from median tumour mutation burden. Among these, somatic mutations in SLC4A3 had features consistent with meaningful consequences on cellular fitness. Definitive evidence for ABT-SLCs as ‘cancer essential’ or ‘driver genes’ will have to consider microenvironmental context in genomic sequencing because bulk approaches are insensitive to pH heterogeneity within tumours. Moreover, genomic analyses must be validated with phenotypic outcomes (i.e. SLC-carried flux) to appreciate the opportunities for targeting acid-base transport in cancers.Keywords
This publication has 96 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genesBioinformatics, 2013
- Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)Oncology Letters, 2012
- The role of BRAF V600 mutation in melanomaJournal of Translational Medicine, 2012
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis InhibitorsMolecular Cancer Therapeutics, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- A mouse model for Glut-1 haploinsufficiencyHuman Molecular Genetics, 2006
- Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial CellsCancer Research, 2005
- Molecular cloning, primary structure, and expression of the human growth factor-activatable antiporterCell, 1989
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976